Peptides and Sleep: Sights So High

Dr. Chris Winter tackles the hype around peptides, explaining that the term alone means nothing about efficacy or safety. He breaks down the confusing regulatory categories—FDA-approved drugs, compounded preparations, supplements, and gray-market vials—and discusses the FDA advisory panel's rejection of DSIP, the peptide once touted as a deep-sleep promoter. The episode compares the strong clinical evidence for tirzepatide in sleep apnea against the weak data for epitalon and growth-hormone peptides, and ends with five practical questions to ask anyone pushing peptide therapies.